Drug Shortage Report for INVOKAMET
| Report ID | 199839 |
| Drug Identification Number | 02455455 |
| Brand name | INVOKAMET |
| Common or Proper name | INVOKAMET 150/1000MG |
| Company Name | JANSSEN INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE CANAGLIFLOZIN |
| Strength(s) | 1000MG 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2023-12-18 |
| Actual start date | |
| Estimated end date | 2024-01-06 |
| Actual end date | 2023-10-13 |
| Shortage status | Avoided shortage |
| Updated date | 2023-10-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-10-13 | French | Compare |
| v5 | 2023-10-13 | English | Compare |
| v4 | 2023-09-13 | French | Compare |
| v3 | 2023-09-13 | English | Compare |
| v2 | 2023-07-24 | French | Compare |
| v1 | 2023-07-24 | English | Compare |
Showing 1 to 6 of 6